Research (33) demonstrated that patients with high hENT1 expression had a significantly higher median survival compared with patients with low hENT1 expression for those who received adjuvant GEM after undergoing surgical resection for pancreatic cancer. This evidence concerns the gene SLC29A1 and familial pancreatic carcinoma.